The drug companies insist they’re doing nothing wrong. They’re merely settling some patent infringement suits.
Many others assert, however, that there’s something fishy about these settlements between the brand name companies that own patents on blockbuster drugs and the generic drug makers that allegedly infringed those patents. Instead of the alleged wrongdoers paying hefty sums to settle the allegations against them (as is typical in any settlement), the money goes the other way. The defendants receive hundreds of millions of dollars from the patentees.
